Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $247.37 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $102.06 | 6 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $77.81 | 4 | $0 (2023) |
| Echosens North America, Inc. | $22.65 | 1 | $0 (2024) |
| PFIZER INC. | $16.48 | 1 | $0 (2023) |
| Lilly USA, LLC | $14.64 | 1 | $0 (2024) |
| Novo Nordisk Inc | $13.73 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69.30 | 4 | ABBVIE INC. ($32.01) |
| 2023 | $117.31 | 7 | ABBVIE INC. ($70.05) |
| 2022 | $16.80 | 1 | Supernus Pharmaceuticals, Inc. ($16.80) |
| 2021 | $43.96 | 2 | Supernus Pharmaceuticals, Inc. ($43.96) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Elastography | ||||||
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: PSYCHOLOGY | ||||||
| 10/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: PSYCHOLOGY | ||||||
| 12/06/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: PSYCHOLOGY | ||||||
| 08/25/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $25.34 | General |
| Category: PSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 182 | 541 | $75,709 | $19,432 |
| 2022 | 4 | 124 | 349 | $55,710 | $15,251 |
| 2021 | 4 | 109 | 445 | $57,582 | $15,564 |
| 2020 | 4 | 79 | 393 | $42,872 | $9,961 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 209 | $49,964 | $14,858 | 29.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 47 | $10,129 | $1,678 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 23 | $7,415 | $1,666 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 27 | $4,374 | $894.42 | 20.4% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 11 | 18 | $831.24 | $171.36 | 20.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 38 | 217 | $2,997 | $164.14 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 152 | $36,337 | $10,813 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 31 | $9,995 | $2,932 | 29.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 37 | $7,597 | $1,398 | 18.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 23 | 129 | $1,781 | $107.79 | 6.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 108 | $25,818 | $7,939 | 30.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 62 | $19,989 | $5,973 | 29.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 20 | 38 | $8,501 | $1,451 | 17.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 20 | 237 | $3,273 | $200.67 | 6.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 118 | $28,209 | $7,434 | 26.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 14 | 35 | $8,682 | $1,363 | 15.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 18 | $2,916 | $931.50 | 31.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 15 | 222 | $3,066 | $231.66 | 7.6% |
About Percy Lynchard, ARNP
Percy Lynchard, ARNP is a Family healthcare provider based in Olympia, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1881108553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Percy Lynchard, ARNP has received a total of $247.37 in payments from pharmaceutical and medical device companies, with $69.30 received in 2024. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($247.37).
As a Medicare-enrolled provider, Lynchard has provided services to 494 Medicare beneficiaries, totaling 1,728 services with total Medicare billing of $60,207. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Olympia, WA
- Active Since 11/16/2017
- Last Updated 03/26/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881108553
Products in Payments
- UBRELVY (Drug) $83.25
- QELBREE (Drug) $77.81
- FibroScan (Device) $22.65
- VRAYLAR (Drug) $18.81
- PAXLOVID (Drug) $16.48
- MOUNJARO (Drug) $14.64
- Ozempic (Drug) $13.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Olympia
Benjamin Matthews, Arnp, ARNP
Family — Payments: $9,981
Mr. Harvey Hall, Fnp-C, Pmhnp-Bc, FNP-C, PMHNP-BC
Family — Payments: $4,827
Katrina Stringer, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $2,385
Michelle Hood
Family — Payments: $1,709
Margaret Ngumi, Fnp-C Pmhnp-Bc, FNP-C PMHNP-BC
Family — Payments: $1,363
Sarah Lukasik, Fnp-C, FNP-C
Family — Payments: $1,284